Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1600107	重组人源化抗PD-1单克隆抗体注射液	Recombinant humanized anti-PD-1 monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2017-02-22	泰州翰中生物医药有限公司	Taizhou Hanzhong Biomedical Co Ltd	Certificate Issued	2017-09-14	view
CXSL2000011	重组人源化抗PD-1单克隆抗体注射液	Recombinant humanized anti-PD-1 monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2020-01-18	泰州翰中生物医药有限公司	Taizhou Hanzhong Biomedical Co Ltd	In Review	2020-01-17	view
CXSL2000022	重组人源化抗PD-1单克隆抗体注射液	Recombinant humanized anti-PD-1 monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2020-02-14	泰州翰中生物医药有限公司	Taizhou Hanzhong Biomedical Co Ltd	In Review	2020-02-13	view